期刊文献+

乌司他丁对体外循环冠脉搭桥患者心肌酶谱的影响 被引量:1

Effect of ulinastatin on perioperative zymogram of cardiac muscle in conventional coronary artery bypass
下载PDF
导出
摘要 目的研究乌司他丁对体外循环下冠脉搭桥术患者术后期心肌酶谱的影响。方法20例择期体外循环下冠脉搭桥术病人随机分为2组:乌司他丁(U组)及对照组(C组),U组术中应用乌司他丁90万IU,C组对应注射等量生理盐水。观察麻醉前、手术当晚、术后第1、第2、第3、第4及第5天的心肌酶谱(GOT、CK、CK-M B、LDH)变化情况。结果C组CK-M B于术后第1天增高;但U组CK-M B与术前相比差异无统计学意义。U组CK-M B、CK、LDH值在术后第1、2天与对照组相比减低。结论在体外循环冠脉搭桥术中使用乌司他丁对围术期心功能具有保护作用。 Objective To study the effect of ulinastatin on perioperative zymogram of cardiac muscle in conventional coronary artery bypass. Methods Twenty patients Who scheduled to undergo conventional coronary artery bypass were divided into control group (Group C) and ulinastatin group (Group U) randomly. Group U were given ulinastatin 900 000 IU while Group C were given the same dose of sodium chloride during operation. The zymogram of cardiac muscle (GOT, CK,CK-MB,LDH) were observed before operation, the first night after operation, the first, second, third, fourth, and fifth days after operation. Results The concentration of CK-MB was elevated in Group C in the first day after operation (P〈0. 05) but Group U had no statistic difference (P〉0.05). CK-MB,CK,and LDH were lower in Group U than Group C in the first and second days after operation (P〈0.01). Conclusion Ulinastatin can protect perioperative heart function in coronary bypass under extracorporeal circulation.
出处 《西部医学》 2007年第3期366-367,共2页 Medical Journal of West China
关键词 乌司他丁 心肌酶谱 体外循环 冠脉搭桥 Ulinastatin Zymogram of cardiac muscle Extracorporeal circulation Coronary artery bypass
  • 相关文献

参考文献5

二级参考文献20

  • 1李李,沈金美,何小京,常业恬.乌司他丁对体外循环患者血浆细胞因子水平及呼吸指数的影响[J].中华麻醉学杂志,2004,24(8):578-581. 被引量:29
  • 2Maekawa N, Wada H, Kanda T, et al. Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha[J]. J Am Coll Cardiol, 2002, 39(7):1229-1235.
  • 3Scalia R, Appel JZ 3rd, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1[J]. Arterioscler Thromb Vasc Biol, 1998,18(7):1093-10100.
  • 4Hall RI, Smith MS, Rocjer G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations[J]. Anesth Analog, 1997,85(4):766-782.
  • 5Sato Y, Ishikawa S, Otaki A, et al. Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastin. Inhibiting cytokines and postoperative organ injury[J]. Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 6Wan S, Le Clerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass[J]. Chest,1997,112(3):676-692.
  • 7Boyle EM, Pohlman TH, Johnson MC, et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response[J]. Ann Thorac Surg, 1997, 63(1):277-284.
  • 8Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operation[J]. Ann Thorac Surg,1996,61(5):1714-1720.
  • 9Nakamura H,Abe S,Shibata Y,et al.Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells[J].Int Arch Allergy Immunol,1997,112(2):157-162.
  • 10Pugia MJ,Takemura T,Kuwajima S,et al.Clinical utility of a rapid test for uristatin[J].Clin Biochem,2002,35 (2):105-110.

共引文献70

同被引文献6

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部